Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.
Actively Recruiting
Researchers are conducting a multi-center observational study to collect long-term clinical outcome data for patients undergoing anatomic or reverse total shoulder arthroplasty shoulder replacement using the Shoulder Innovations Total Shoulder System device. The study aims to evaluate both short- and long-term clinical and radiographic results associated with real-world use of this shoulder arthroplasty system, following patients from the implant procedure through 10 years post-operation. Participants include those who plan to receive or have already received shoulder arthroplasty with at least one Shoulder Innovations device component implanted. The study gathers standard-of-care data without randomization, monitoring outcomes such as range of motion, patient-reported scores, radiographic images, and device durability over a decade. Patients will complete specific patient-reported outcome measures consistently before and after surgery. Throughout the study, participants will be followed with evaluations of clinical function, imaging for implant stability, and assessments of any device-related complications. These assessments occur at multiple timepoints from before surgery up to 10 years after. The main outcome is the durability of the implanted device components, along with changes in motion and functional scores, monitored during long-term follow-up conducted by study investigators.